Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-31FDA Approved: SPRAVATO — Supplemental Application (Janssen Pharmaceuticals Inc.)
The FDA approved Janssen's supplemental application for SPRAVATO (esketamine hydrochloride), updating its labeling to reflect the approved s…
-
FDA approval · 2025-07-15FDA Approved: ESCITALOPRAM OXALATE — Original Application (Ascent Pharmaceuticals, Inc)
FDA approved escitalopram oxalate as a generic product for Ascent Pharmaceuticals, Inc (ANDA 215177). It is intended to be used for the same…
-
FDA approval · 2025-07-11FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for fluoxetine hydrochloride submitted by Quallent Pharmaceuticals Health LLC, indicating an update …
-
FDA approval · 2025-07-08FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited to market the generic product for the same ind…
-
FDA approval · 2025-07-03FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Bupropion Hydrochloride XL, adding an extended-release formulation of bupro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-27FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for Amitriptyline Hydrochloride, resulting in changes to the approved pr…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., authorizing changes to the produc…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application for trazodone hydrochloride by Aurolife Pharma LLC, indicating a regulatory action on this generic p…
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Centaur Pharmaceuticals Private Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Centaur Pharmaceuticals Private Limited to continue marketing t…
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for amitriptyline hydrochloride by Advagen Pharma Ltd, indicating an approved change to an alrea…
-
FDA approval · 2025-06-24FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approves a supplemental application for Norpramin (desipramine hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2025-06-24FDA Approved: IMIPRAMINE PAMOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc)
FDA approved a supplemental application for Imipramine Pamoate by Hikma Pharmaceuticals USA Inc, enabling a generic imipramine pamoate produ…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved Oxford Pharmaceuticals' supplemental application for trazodone hydrochloride (generic antidepressant) under ANDA 072193.
-
FDA approval · 2025-06-24FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for imipramine hydrochloride from Strides Pharma Science Limited, enabling continued market avai…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Rising Pharma Holdings, Inc., allowing the generic product to b…
-
FDA approval · 2025-06-24FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for imipramine hydrochloride (generic) from Oxford Pharmaceuticals, LLC. The action updates the labe…
-
FDA approval · 2025-06-24FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Bupropion hydrochloride extended-release (XL), enabling the generic XL prod…
-
FDA approval · 2025-06-24FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic Perphenazine and Amitriptyline Hydrochloride product by Mylan Pharmaceuticals.
-
FDA approval · 2025-06-24FDA Approved: NEFAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for nefazodone hydrochloride (Teva Pharmaceuticals USA, Inc.) to modify aspects of the product u…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for trazodone hydrochloride from Apotex Corp, authorizing updated or additional approval details…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride tablets from Accord Healthcare, Inc., effectively approving a generi…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for trazodone hydrochloride, confirming a generic version of the antidepressant.
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Amitriptyline hydrochloride from Sandoz Inc under an Abbreviated New Drug Application (ANDA).
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Sun Pharmaceutical Industries, Inc., enabling a generic version…
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, authorizing a generic product's appro…